Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Debt Ratio (2020 - 2025)

Rani Therapeutics Holdings' Debt Ratio history spans 6 years, with the latest figure at 1.34 for Q3 2025.

  • On a quarterly basis, Debt Ratio rose 105.38% to 1.34 in Q3 2025 year-over-year; TTM through Sep 2025 was 1.34, a 105.38% increase, with the full-year FY2024 number at 0.67, up 32.44% from a year prior.
  • Debt Ratio came in at 1.34 for Q3 2025, up from 1.02 in the prior quarter.
  • The five-year high for Debt Ratio was 1.34 in Q3 2025, with the low at 0.0 in Q2 2022.
  • Historically, Debt Ratio has averaged 0.46 across 5 years, with a median of 0.42 in 2023.
  • Biggest five-year swings in Debt Ratio: tumbled 99.43% in 2022 and later skyrocketed 121791.07% in 2023.
  • Year by year, Debt Ratio stood at 0.0 in 2021, then skyrocketed by 26499.1% to 0.27 in 2022, then skyrocketed by 88.01% to 0.51 in 2023, then surged by 32.44% to 0.67 in 2024, then soared by 98.72% to 1.34 in 2025.
  • Business Quant data shows Debt Ratio for RANI at 1.34 in Q3 2025, 1.02 in Q2 2025, and 0.87 in Q1 2025.